title: Interferons: unapproved uses, dosages, or indications.
authors.affiliation: Dermatology Unit, Kaplan Medical Center, Rehovot, Israel.
authors.forename: Edith
authors.initials: E
authors.lastname: Orion
authors.forename: Hagit
authors.initials: H
authors.lastname: Matz
authors.forename: Ronni
authors.initials: R
authors.lastname: Wolf
mesh_terms: D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D004363:Drug Utilization; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D007372:Interferons / Q000008:administration & dosage* / Q000009:adverse effects*; D007557:Israel; D008297:Male; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012871:Skin Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D007372:Interferons